Assignee
ADOCIA
FR·33 granted patents·50 pending applications·60 citations·filing 2008–2024
Top patents by PatentIndex Score
83 records- 0193US10646551B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2019·Granted May 12, 2020·3 cites·26 claims
- 0293US9457089B2Highly concentrated aqueous protein solution with reduced viscosityADOCIA·Filed 2013·Granted Oct 4, 2016·13 cites·21 claims
- 0387US9492467B2Rapid-acting insulin formulation comprising an oligosaccharideADOCIA·Filed 2014·Granted Nov 15, 2016·3 cites·32 claims
- 0485US9795678B2Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compoundADOCIA·Filed 2015·Granted Oct 24, 2017·3 cites·27 claims
- 0585US9278131B2Process for lowering the viscosity of highly concentrated protein solutionsADOCIA·Filed 2013·Granted Mar 8, 2016·9 cites·30 claims
- 0684US11065305B2Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial actionADOCIA·Filed 2020·Granted Jul 20, 2021·1 cites·19 claims
- 0784US10881716B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2020·Granted Jan 5, 2021·1 cites·7 claims
- 0881US10610572B2Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial actionADOCIA·Filed 2018·Granted Apr 7, 2020·2 cites·20 claims
- 0981US8367640B2Complex consisted of a polysaccharide and an HBPADOCIA·Filed 2009·Granted Feb 5, 2013·3 cites·12 claims
- 1080US10583175B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2017·Granted Mar 10, 2020·2 cites·33 claims
- 1180US9700599B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2013·Granted Jul 11, 2017·3 cites·14 claims
- 1279US10485851B2Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2017·Granted Nov 26, 2019·3 cites·16 claims
- 1378US11191812B2Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2018·Granted Dec 7, 2021·1 cites·17 claims
- 1478US10463717B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acidADOCIA·Filed 2017·Granted Nov 5, 2019·3 cites·12 claims
- 1578US10383918B2Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acidADOCIA·Filed 2017·Granted Aug 20, 2019·3 cites·15 claims
- 1678US2025099551A1Thermostable formulation of a21g human insulinADOCIA·Filed 2024·Application pending·0 cites
- 1776US11324808B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2020·Granted May 10, 2022·0 cites·22 claims
- 1876US10548952B2Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2017·Granted Feb 4, 2020·2 cites·36 claims
- 1976US10383920B2Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2017·Granted Aug 20, 2019·2 cites·18 claims
- 2075US11633460B2Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2018·Granted Apr 25, 2023·2 cites·15 claims
- 2175US2025090638A1Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acidADOCIA·Filed 2024·Application pending·0 cites
- 2270US10792335B2Rapid-acting insulin composition comprising a substituted citrateADOCIA·Filed 2016·Granted Oct 6, 2020·1 cites·21 claims
- 2369US2019216931A1Injectable ph 7 solution comprising at least one basal insulin having a pi from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2018·Application pending·0 cites
- 2467US2024115663A1Compositions comprising at least an insulin and an amylin receptor agonist for treating diabetes, in a patient/person having a bmi of more than 28 kg/m² and/or an hba1c of more than 7.6%ADOCIA·Filed 2023·Application pending·0 cites
- 2565US11707507B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acidADOCIA·Filed 2019·Granted Jul 25, 2023·0 cites·1 claims
- 2664US12186373B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acidADOCIA·Filed 2021·Granted Jan 7, 2025·0 cites·12 claims
- 2764US2011027363A1Nouvelle forme d'administration de proteines osteogeniquesADOCIA·Filed 2009·Application pending·0 cites
- 2864US2021315977A1Thermostable formulation of a21g human insulinADOCIA·Filed 2019·Application pending·0 cites
- 2964US2026027047A1Hydrogels for cell therapyADOCIA·Filed 2023·Application pending·0 cites
- 3063US2018311316A1Injectable solution at ph 7 comprising at least one basal insulin whose pi is between 5.8 and 8.5ADOCIA·Filed 2018·Application pending·0 cites
- 3162US2015314003A2Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymerADOCIA·Filed 2014·Application pending·0 cites
- 3262US2022409523A1Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acidADOCIA·Filed 2021·Application pending·0 cites
- 3361US10449256B2Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymerADOCIA·Filed 2018·Granted Oct 22, 2019·0 cites·10 claims
- 3461US2014235536A1Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is comprised in 5.8 and 8.5 and an anionic compound bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2014·Application pending·0 cites
- 3561US2021205417A1Ph 7 injectable solution comprising at least one basal insulin of which the pi is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals and a limited amount of m-cresolADOCIA·Filed 2021·Application pending·0 cites
- 3660US2009291114A1Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic supportADOCIA·Filed 2009·Application pending·0 cites
- 3760US2021386830A1Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2021·Application pending·0 cites
- 3859US11883496B2Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2020·Granted Jan 30, 2024·0 cites·24 claims
- 3959US2020179489A1Injectable solution at ph 7 comprising at least one basal insulin which pi is from 5.8 to 8.5 and a co-polyamino-acid bearing carboxylate charges and hydrophobic radicals and a limited amount of m-cresolADOCIA·Filed 2018·Application pending·0 cites
- 4058US12421327B2Hydrogels for cell therapyADOCIA·Filed 2022·Granted Sep 23, 2025·0 cites·18 claims
- 4158US2018236085A1Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is comprised in 5.8 and 8.5 and an anionic compound bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2018·Application pending·0 cites
- 4258US2009291113A1Osteogenic composition comprising a growth factor, a soluble cation salt and organic supportADOCIA·Filed 2009·Application pending·0 cites
- 4358US2017143835A1Substituted anionic compounds consisting of a backbone made up of a discrete number of saccharide unitsADOCIA·Filed 2017·Application pending·0 cites
- 4458US2013231281A1Rapid acting insulin formulation comprising an oligosaccharideADOCIA·Filed 2012·Application pending·0 cites
- 4557US12544349B1Compositions comprising pemvidutide and an acylated amino acidADOCIA·Filed 2024·Granted Feb 10, 2026·0 cites·30 claims
- 4657US2010137456A1Polysaccharides functionalized by tryptophan derivativesADOCIA·Filed 2009·Application pending·0 cites
- 4757US2013245246A1Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivativeADOCIA·Filed 2013·Application pending·0 cites
- 4857US2019275110A1Compositions in the form of an injectale aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2018·Application pending·0 cites
- 4957US2023210957A1Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial actionADOCIA·Filed 2021·Application pending·0 cites
- 5056US11173109B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acidADOCIA·Filed 2018·Granted Nov 16, 2021·0 cites·18 claims
Showing the top 50 of 83 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →